Literature DB >> 29718117

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.

L De Mattos-Arruda, B Weigelt, J Cortes, H H Won, C K Y Ng, P Nuciforo, F-C Bidard, C Aura, C Saura, V Peg, S Piscuoglio, M Oliveira, Y Smolders, P Patel, L Norton, J Tabernero, M F Berger, J Seoane, J S Reis-Filho.   

Abstract

Entities:  

Year:  2018        PMID： 29718117      PMCID： PMC6887917          DOI： 10.1093/annonc/mdx804

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  9 in total

Review 1.  Current Advances and Future Perspectives of Cerebrospinal Fluid Biopsy in Midline Brain Malignancies.

Authors:  Yimin Pan; Wenyong Long; Qing Liu
Journal:  Curr Treat Options Oncol       Date:  2019-11-29

Review 2.  Cell-Free DNA Methylation Profiling Analysis-Technologies and Bioinformatics.

Authors:  Jinyong Huang; Liang Wang
Journal:  Cancers (Basel)       Date:  2019-11-06       Impact factor: 6.639

3.  [Clinical Value of Cerebrospinal Fluid ctDNA in Patients 
with Non-small Cell Lung Cancer Meningeal Metastasis].

Authors:  Kunyu Zhang; Zhaoxia Dai; Siya Liu; Dan Li; Dafu Yang; Saiqiong Cui
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-12-20

4.  Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis.

Authors:  Hayato Koba; Hideharu Kimura; Taro Yoneda; Takashi Sone; Noriyuki Ohkura; Johsuke Hara; Kazuyoshi Hosomichi; Atsushi Tajima; Kazuo Kasahara
Journal:  Sci Rep       Date:  2021-04-16       Impact factor: 4.379

Review 5.  A clinician's handbook for using ctDNA throughout the patient journey.

Authors:  Samantha O Hasenleithner; Michael R Speicher
Journal:  Mol Cancer       Date:  2022-03-21       Impact factor: 27.401

6.  Pre- and post-treatment blood-based genomic landscape of patients with ROS1 or NTRK fusion-positive solid tumours treated with entrectinib.

Authors:  Rafal Dziadziuszko; Tiffany Hung; Kun Wang; Voleak Choeurng; Alexander Drilon; Robert C Doebele; Fabrice Barlesi; Charlie Wu; Lucas Dennis; Joel Skoletsky; Ryan Woodhouse; Meijuan Li; Ching-Wei Chang; Brian Simmons; Todd Riehl; Timothy R Wilson
Journal:  Mol Oncol       Date:  2022-04-22       Impact factor: 7.449

Review 7.  Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.

Authors:  Marco Russano; Andrea Napolitano; Giulia Ribelli; Michele Iuliani; Sonia Simonetti; Fabrizio Citarella; Francesco Pantano; Emanuela Dell'Aquila; Cecilia Anesi; Nicola Silvestris; Antonella Argentiero; Antonio Giovanni Solimando; Bruno Vincenzi; Giuseppe Tonini; Daniele Santini
Journal:  J Exp Clin Cancer Res       Date:  2020-05-27

8.  Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.

Authors:  Andjelija Zivanovic Bujak; Chen-Fang Weng; Maria João Silva; Miriam Yeung; Louisa Lo; Sarah Ftouni; Cassandra Litchfield; Yi-An Ko; Keilly Kuykhoven; Courtney Van Geelen; Sushma Chandrashekar; Mark A Dawson; Sherene Loi; Stephen Q Wong; Sarah-Jane Dawson
Journal:  PLoS Med       Date:  2020-10-01       Impact factor: 11.069

Review 9.  Role of ctDNA in Breast Cancer.

Authors:  Marta Sant; Adrià Bernat-Peguera; Eudald Felip; Mireia Margelí
Journal:  Cancers (Basel)       Date:  2022-01-09       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.